Safety and efficacy outcomes at 1 year after MitraClip therapy for percutaneous mitral valve repair in patients with severe mitral regurgitation: the Egyptian experience

The Egyptian Heart Journal

Table 5 Comparison between non-complicated and complicated groups for demographics

Variables		Not complicated (N = 16)	Complicated (N = 4)	P value
Age (years)	Mean ± SD	64.63 ± 9.21	75.25 ± 12.42	0.069
Age (years)	Range	46-78	57-84	0.069
Gender	Female	2 (12.5%)	1 (25%)	0.531
Gender	Male	14 (87.5%)	3 (75%)	0.531
BSA	Mean ± SD	1.79 ± 0.22	1.69 ± 0.11	0.370
BSA	Range	1.55-2.3	1.55-1.78	0.370
MR etiology	Ischemic	8 (50%)	3 (75%)	0.730
MR etiology	Non-Ischemic	8 (50%)	1 (25%)	0.730
NYHA class Pre	I	0 (0%)	0 (0%)	0.197
	II	0 (0%)	0 (0%)
	III	13 (81.2%)	2 (50%)
	IV	3 (18.8%)	2 (50%)
NYHA class Post	I	12 (75%)	2 (50%)	0.329
	II	4 (25%)	2 (50%)
	III	0 (0%)	0 (0%)
	IV	0 (0%)	0 (0%)
EuroSCORE	Median (IQR)	9.5 (8.5-11.5)	13 (11.5-14.5)	0.028*
EuroSCORE	Range	7-13	11-15	0.028*

N Number, SD Standard deviation, IQR Interquartile range, BSA Body surface area, MR Mitral regurgitation, NYHA New York Heart Association, EuroSCORE European System for Cardiac Operative Risk Evaluation
^*Significant